Fanny Lebossé

1.7k total citations
37 papers, 1.0k citations indexed

About

Fanny Lebossé is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Fanny Lebossé has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hepatology, 23 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Fanny Lebossé's work include Liver Disease Diagnosis and Treatment (18 papers), Hepatitis B Virus Studies (15 papers) and Hepatitis C virus research (15 papers). Fanny Lebossé is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Hepatitis B Virus Studies (15 papers) and Hepatitis C virus research (15 papers). Fanny Lebossé collaborates with scholars based in France, United Kingdom and Italy. Fanny Lebossé's co-authors include Fabien Zoulim, Massimo Levrero, Barbara Testoni, Caroline Scholtès, Françoise Berby, F. Facchetti, Pietro Lampertico, Miroslava Subic, Alessandro Loglio and Judith Fresquet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Fanny Lebossé

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fanny Lebossé France 14 757 720 164 137 103 37 1.0k
Efsevia Albanis United States 11 919 1.2× 882 1.2× 132 0.8× 73 0.5× 96 0.9× 11 1.1k
Arshi Khanam United States 14 390 0.5× 383 0.5× 91 0.6× 140 1.0× 74 0.7× 23 660
Maria Quasdorff Germany 13 510 0.7× 718 1.0× 134 0.8× 179 1.3× 267 2.6× 20 1.0k
Martin‐Walter Welker Germany 13 507 0.7× 412 0.6× 90 0.5× 42 0.3× 262 2.5× 39 867
Samir Ali Denmark 14 488 0.6× 384 0.5× 315 1.9× 86 0.6× 222 2.2× 37 915
Akinobu Takaki Japan 10 741 1.0× 545 0.8× 46 0.3× 176 1.3× 65 0.6× 36 918
M Duffaut France 16 971 1.3× 827 1.1× 108 0.7× 79 0.6× 36 0.3× 49 1.2k
Y‐F Liaw Taiwan 12 648 0.9× 583 0.8× 62 0.4× 120 0.9× 65 0.6× 20 840
Vincent Leroy France 17 828 1.1× 813 1.1× 82 0.5× 307 2.2× 49 0.5× 37 1.1k
Byung‐Cheol Song South Korea 19 965 1.3× 792 1.1× 83 0.5× 36 0.3× 179 1.7× 60 1.3k

Countries citing papers authored by Fanny Lebossé

Since Specialization
Citations

This map shows the geographic impact of Fanny Lebossé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Lebossé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Lebossé more than expected).

Fields of papers citing papers by Fanny Lebossé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanny Lebossé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Lebossé. The network helps show where Fanny Lebossé may publish in the future.

Co-authorship network of co-authors of Fanny Lebossé

This figure shows the co-authorship network connecting the top 25 collaborators of Fanny Lebossé. A scholar is included among the top collaborators of Fanny Lebossé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanny Lebossé. Fanny Lebossé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freymond, N., Gilles Boschetti, Fanny Lebossé, et al.. (2024). Evolving Practices in Immune-Related Adverse Event Management: Insights From the IMMUCARE Multidisciplinary Board. JCO Oncology Practice. 21(3). 342–350. 3 indexed citations
2.
Lebossé, Fanny, Xavier Quantin, C. Lesage, et al.. (2023). Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort. JHEP Reports. 5(6). 100719–100719. 43 indexed citations
3.
Gossez, Morgane, Térésa Antonini, Fabien Zoulim, et al.. (2023). Assessment of neutrophil subsets and immune checkpoint inhibitor expressions on T lymphocytes in liver transplantation: A preliminary study beyond the neutrophil-lymphocyte ratio. Frontiers in Physiology. 14. 1095723–1095723. 2 indexed citations
4.
Lebossé, Fanny, Marie‐Laure Plissonnier, Jean‐Christophe Lega, et al.. (2023). Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis. iScience. 26(8). 107427–107427. 1 indexed citations
5.
Liu, Tong, et al.. (2023). Dysfunctions of Circulating Adaptive Immune Cells in End-Stage Liver Disease. SHILAP Revista de lepidopterología. 3(3). 369–382. 2 indexed citations
6.
Mascaux, Céline, M. Zysman, Aurélie Swalduz, et al.. (2022). 37P Sotorasib-induced liver and non-liver toxicity associated with sequential sotorasib following anti-PD(L)1 in KRASG12C mutant lung cancer. Annals of Oncology. 33. S49–S50. 5 indexed citations
7.
Khamri, Wafa, Cathrin Gudd, Tong Liu, et al.. (2021). Suppressor CD4+T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis. Gut. 71(6). 1192–1202. 7 indexed citations
8.
Lebossé, Fanny, Maëlle Locatelli, Judith Fresquet, et al.. (2020). Quantification and epigenetic evaluation of the residual pool of hepatitis B covalently closed circular DNA in long-term nucleoside analogue-treated patients. Scientific Reports. 10(1). 21097–21097. 31 indexed citations
9.
Lebossé, Fanny & Fabien Zoulim. (2020). Vaccination contre le virus de l’hépatite B et prévention du cancer du foie. Bulletin du Cancer. 108(1). 90–101. 13 indexed citations
10.
Lebossé, Fanny, Cathrin Gudd, Arjuna Singanayagam, et al.. (2019). CD8+ T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction. EBioMedicine. 49. 258–268. 69 indexed citations
11.
Testoni, Barbara, Fanny Lebossé, Caroline Scholtès, et al.. (2018). Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients. Journal of Hepatology. 70(4). 615–625. 199 indexed citations
12.
Lebossé, Fanny, et al.. (2018). Enjeux de la prise en charge du virus de l’hépatite B (VHB) en transplantation. Virologie. 22(6). 277–288. 1 indexed citations
13.
Khamri, Wafa, R.D. Abeles, Tie Zheng Hou, et al.. (2017). Increased Expression of Cytotoxic T-Lymphocyte−Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure. Gastroenterology. 153(1). 263–276.e8. 37 indexed citations
14.
Bernsmeier, Christine, Evangelos Triantafyllou, Fanny Lebossé, et al.. (2017). CD14 + CD15 − HLA-DR − myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure. Gut. 67(6). 1155–1167. 100 indexed citations
15.
Lebossé, Fanny, Barbara Testoni, Judith Fresquet, et al.. (2016). Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B. Journal of Hepatology. 66(5). 897–909. 122 indexed citations
16.
Zoulim, Fabien, Fanny Lebossé, & Massimo Levrero. (2016). Current treatments for chronic hepatitis B virus infections. Current Opinion in Virology. 18. 109–116. 71 indexed citations
17.
Plissonnier, Marie‐Laure, Thomas Lahlali, Maud Michelet, et al.. (2016). Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus. PLoS Biology. 14(3). e1002421–e1002421. 14 indexed citations
18.
Testoni, Barbara, David Durantel, Fanny Lebossé, et al.. (2015). Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes. Gut. 65(4). 672–682. 13 indexed citations
19.
Pradat, Pierre, Victor Virlogeux, Marianne Maynard, et al.. (2015). Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy. Hepatitis Monthly. 15(9). e28879–e28879. 1 indexed citations
20.
Miailhes, Patrick, M. Maynard-Muet, Fanny Lebossé, et al.. (2014). Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study. Journal of Hepatology. 61(4). 761–769. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Efsevia Albanis Breakdown of academic impact, for papers by Arshi Khanam Breakdown of academic impact, for papers by Maria Quasdorff Breakdown of academic impact, for papers by Martin‐Walter Welker Breakdown of academic impact, for papers by Samir Ali Breakdown of academic impact, for papers by Akinobu Takaki Breakdown of academic impact, for papers by M Duffaut Breakdown of academic impact, for papers by Y‐F Liaw Breakdown of academic impact, for papers by Vincent Leroy Breakdown of academic impact, for papers by Byung‐Cheol Song
Rankless by CCL
2026